Exchange: NYSEMkt·Updated 10:05 PM EST

SENS News

News
all
press releases
Senseonics (NASDAQ:SENS) Stock: Insider Douglas Roeder Acquires 17,041 Shares
Senseonics Holdings, Inc. (NASDAQ:SENS - Get Free Report) Director Douglas Roeder acquired 17,041 shares of the firm's stock in a transaction dated Friday, November 13th. The stock was bought at an average cost of $10.32 per share, with a total value of $175,863.12. Following the acquisition, the...
MarketBeat
Senseonics (NASDAQ:SENS) Stock: Insider Douglas Roeder Acquires 17,041 Shares
Senseonics Holdings, Inc. (NASDAQ:SENS - Get Free Report) Director Douglas Roeder acquired 17,041 shares of the firm's stock in a transaction dated Friday, November 13th. The stock was bought at an average cost of $10.32 per share, with a total value of $175,863.12. Following the acquisition, the...
MarketBeat
More News
Wall Street Zen upgraded shares of Senseonics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat
Earnings Gaps Meet the Moving Averages on a Softer Morning for Stocks Earnings Gaps Meet the Moving Averages on a Softer Morning for StocksPR NewswireNEW YORK, Nov. 10, 2026 NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Stock Preachers News Commentary- The Bureau of Labor Statistics reported Tuesday...
PR Newswire
Shares of Senseonics Holdings Inc (NASDAQ:SENS) are trading higher on Tuesday after the company reported better-than-expected third-quarter financial results and raised its fiscal 2026 revenue guidance above estimates. Raymond James also upgraded the stock to Market Perform from Underperform.read...
Benzinga
Senseonics (SENS) delivered earnings and revenue surprises of -2.04% and +19.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Evolent Health (EVH) delivered earnings and revenue surprises of 0.00% and -1.22%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Senseonics Holdings (AMEX:SENS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-timeread more...
Benzinga
BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insulin delivery ecosystem across iLet and mint.
Zacks
Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a value trap. Senseonics Holdings (NASDAQ: SENS) posts upbeat sales and Ubiquiti (NYSE: UI) reports worse-than-expected results. Hess Midstream (NYSE: HESM) is a winner while Zeta Global (NYSE: ZETA...
Benzinga
DexCom's broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.
Zacks

Advertisement|Remove ads.